Advent Pharma (DHA:ADVENT) Change In Receivables: BDT0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:ADVENT Advent Pharma Ltd DHA:ADVENT
32 GF Score
Price BDT15.20
View Full Analysis

What is Advent Pharma Change In Receivables?

Advent Pharma DHA:ADVENT 32 Change In Receivables is BDT0.00 Mil as of . 20. GuruFocus rates DHA:ADVENT with a GF Score™ of 32/100.

Advent Pharma's change in receivables for the quarter that ended in . 20 was BDT0.00 Mil. It means Advent Pharma's Accounts Receivable stayed the same from . 20 to . 20 .

Advent Pharma's change in receivables for the fiscal year that ended in . 20 was BDT0.00 Mil. It means Advent Pharma's Accounts Receivable stayed the same from . 20 to . 20 .

Advent Pharma's Accounts Receivable for the quarter that ended in . 20 was BDT0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Advent Pharma's liquidation value for the six months ended in . 20 was BDT0.00 Mil.

Advent Pharma  (DHA:ADVENT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Advent Pharma's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=/*91
=

2. In Ben Graham's calculation of liquidation value, Advent Pharma's accounts receivable are only considered to be worth 75% of book value:

Advent Pharma's liquidation value for the quarter that ended in . 20 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=-+0.75 * +0.5 *
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Change In Receivables Related Terms

Advent Pharma Change In Receivables Historical Data

* Premium members only.

The historical data trend for Advent Pharma's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advent Pharma Change In Receivables Chart

Advent Pharma Annual Data
Trend
Change In Receivables

Advent Pharma Semi-Annual Data
Change In Receivables
DHA:ADVENT
32GF Score
Advent Pharma Ltd DHA:ADVENT
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advent Pharma Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of BDT0.00 Mil mean?
Advent Pharma (DHA:ADVENT) has a Change In Receivables of BDT0.00 Mil as of . 20. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Advent Pharma and its competitors.
Is Advent Pharma's Change In Receivables too high?
Advent Pharma's current Change In Receivables is BDT0.00 Mil. Overall, Advent Pharma has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Advent Pharma's Change In Receivables compare to ?
Advent Pharma's Change In Receivables of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Advent Pharma and its competitors. Advent Pharma's current Change In Receivables is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advent Pharma stock overvalued right now?
Advent Pharma (DHA:ADVENT) has a current Change In Receivables of BDT0.00 Mil. The current Change In Receivables is BDT0.00 Mil. Advent Pharma's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Advent Pharma (DHA:ADVENT), the current Change In Receivables is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advent Pharma Business Description

Comparable Companies
Address Kakrail V.I.P. Road, Level no. 10, 80, Rupayan Karim Tower, Kakrail, Ramna, Dhaka, BGD, 1000
Advent Pharma Ltd is a Bangladesh-based company engaged in producing animal healthcare drugs and nutritional supplements for livestock.
32GF Score

Get the complete analysis for DHA:ADVENT

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.20
Price